INK4a expression is critical to preserve the proliferative capacity of stem cells, the molecular mechanisms responsible for silencing p16
INTRODUCTION
Self-renewal of stem cells is vital for maintaining tissues homeostasis throughout the life span of an organism. Because of their highmitotic activity, stem cells have to put in place inherent cellular defense mechanisms, such as senescence and apoptosis, to avoid the expansion of potentially malignant cells resulting from the accumulation of oncogenic mutations. Cells undergoing senescence display dramatic changes in chromatin structure, which contribute to the irreversible nature of the senescent state. These changes are regulated by the activities of chromatin modifying enzymes; however, the nature of these specific enzymes and their role in the control of senescence remains mostly unknown.
The histone acetyltranferase monocytic leukemia zinc finger protein (MOZ; MYST3 or KAT6A) is a key regulator of hematopoiesis recurrently found translocated in acute myeloid leukemia [1] [2] [3] [4] [5] . Both MOZ null mouse embryos and mice carrying a G657E mutation, which renders the protein catalytically inactive (Moz HAT2/2 hereafter), have severe defects in the generation and maintenance of hematopoietic stem cells (HSCs) [6] [7] [8] . In the absence of MOZ histone acetyltransferase (HAT) activity, the proliferative capacity of hematopoietic progenitors is dramatically impaired, with many cells withdrawing from the cell cycle during the G1 phase [8] .
In this study, we establish that the proliferative defect observed in the absence of the HAT activity of MOZ is not limited to the hematopoietic compartment, but also extends to neural stem cells and progenitors (NSC/Ps). We show that this proliferative defect is caused by the upregulation of p16
INK4a expression leading to a premature entry into replicative senescence and that the senescent phenotype can be rescued by genetic deletion of p16
INK4a . We further demonstrate that MOZ binds directly to the promoter of p16
INK4a indicating that this tumor suppressor is a direct target of MOZ. Our findings suggest that these two stem cell types, HSCs and NSCs, use the same novel mechanism involving MOZ-driven acetylation to maintain their capacity to proliferate and avoid senescence. Altogether, these results provide new insights into the control of stem and progenitor cell proliferation and identify an unexpected role of MOZ-mediated acetylation in the regulation of p16
INK4a
expression. This finding also suggests that a potential reinforcement of the repressive activity of MOZ on p16
INK4a expression could be an important mechanism supporting the development of acute myeloid leukemia following MOZ translocations. 
TISSUE-SPECIFIC STEM CELLS MATERIALS AND METHODS

Cell Culture and Growth Curves
Differentiation of embryonic stem cells (ESCs) into embryoid bodies (EBs) was carried out as described previously [8, 9] . Serum-free conditions that sustain the proliferation of hematopoietic precursors in liquid culture were described previously [10] . For neurospheres culture, we used the "NeuroCult Proliferation Kit" (Stem Cell Technologies, www.stemcell.com). To test the self-renewal capacity of neurospheres, cells were isolated from primary spheres using a NeuroCult Chemical Dissociation Kit (Stem Cell Technologies, www.stemcell.com). Self-renewal was quantified as number of secondary neurospheres generated per primary neurosphere. For proliferation studies, 10 mM 5-bromo-2-deoxyuridine (BrdU) was added to the cultures for 12 hours at 37 C.
Expression Analysis
Total RNA was extracted with an RNAeasy kit, treated with RNAse-free DNase (QIAGEN, www.qiagen.com), and reversetranscribed into cDNA with random hexamers by use of an Omniscript RT kit (QIAGEN, www.qiagen.com). Real-time polymerase chain reaction (PCR) was performed on an ABI 7900 system (Applied Biosystems, www.lifetechnologies.com) using the Exiqon universal probe library and primer designer (Roche, www.roche.com). All expression data were calculated relative to b-actin as 2 2Dct . Data are presented as DCt values from triplicates normalized to b-actin. Primer sequences are available upon request.
Flow Cytometry
EBs were trypsinized (TryplE; Life technologies, www.lifetechnologies.com) for 3 minutes. Bone marrow of transplanted NOD Scid Gamma NSG mice was isolated by flushing the femurs with phosphate-buffered saline containing 2% fetal bovine serum. Singlecell suspensions were analyzed on a FACScan or a FACScalibur flow cytometer (Becton Dickinson, www.bd.com) or sorted on a FACS Vantage cell sorter (Becton Dickinson). The antibodies used were as follows: Mac1 (biotinylated), Sca-1 labelled with fluorescein isothiocyanate (FITC), and c-Kit (APC) were used for the HSC analysis; For the isolation of Lin 2 cKit 2 or CD45.2 1 Lin 2 cKit 1 population from bone marrow, we used CD45.2 (Biotin) and cKit labelled with allophycocyanin (APC) antibody together with a mix of antibodies recognizing lineage specific antigens Gr1, Mac1, B220, CD3, and Ter119 (PE). Staining with CD34 (Biotin) and cKit (APC) was performed to isolate hematopoietic progenitors from day 6 EBs. For the isolation of HSCs, we also included a combination of antibodies recognizing members of the SLAM markers CD150 (PE), CD48 (APC), and CD224.2 (FITC). All the antibodies were from BD Pharmingen or ebiosciences. For cell cycle analysis, BrdU incorporation (BrdU Flow kit, BD Pharmingen, www.bdbiosciences.com) was performed according to the manufacturer's instructions.
Senescence Analysis
Senescence associated b-galactosidase (SA b-gal) assay was performed using a senescence b-galactosidase staining kit (Cell Signaling, www.cellsingal.com). INK4a expression by immunostaining. Sorted 6-day 5FU cells were grown in liquid culture in round-bottom microtiter plates (10 cells per well). After 10 days of incubation, cell number per well was scored using an inverted light microscope.
Fetal Liver Transplantation and 5FU Treatment
Competitive Repopulation Assays
Experimental conditions for this assay were published previously [11] . Repopulating units (RUs) from each donor were calculated according to the method described by Harrison and Astle [12] , where numbers of RUs are calculated from the percentage donor cells. In brief, the calculations are based in the formula RU 5 %(C)/(100 2 %), where the number of fresh competitor marrow cells used per 10 5 equals C and percentage corresponds to the obtained percentage of donor cells. 
Transgenic Mice and Embryo Generation
ChIP Assays
Chromatin immunoprecipitation was performed using the Red ChIP Kit (Diagenode, www.diagenode.com) following the instructions of the manufacturer. 
Immunoblotting and Immunocytochemistry
To analyze protein expression levels, cells were solubilized in Radio-Immunoprecipitation Assay (RIPA) lysis buffer containing a cocktail of protease inhibitors (Sigma Aldrich). Electrophoresis was carried out using commercial reagents (Novex; Life Technologies, www.lifetechnologies.com). For immunoblot, proteins were transferred to a nitrocellulose membrane using the iBlot gel transfer apparatus (Life Technologies, www.lifetechnologies.com). Nonspecific binding was blocked by incubation in blocking buffer; Tris-buffered saline (TBST; 0.1% Tween-20) containing 5% skimmed milk. After incubation with the corresponding secondary antibodies, signal was developed using the Enhanced Chemiluminescence Plus kit (ECL-Plus kit; GE-Healthcare Bio-Sciences, www.gelifesciences.com). For p16 INK4a and HP1-c immunostainings cells were cytocentrifuged, fixed and stained with the corresponding antibody. Antibodies used were HP1-c (07332 from Millipore, 1A) . A significantly higher percentage of the hematopoietic progenitors also expressed the senescence-associated bgalactosidase (SA b-gal) in the absence of the HAT activity of MOZ (Fig. 1B) . The progression through the G1 phase of the cell cycle in stem cells has been shown to be controlled by different cyclin-dependent kinase (CDK) inhibitors, such as p16(INK4a) [14] [15] [16] , p21(CIP1) [16] [17] [18] [19] [20] , p27 (Kip1) [21, 22] , and p57(Kip2) [23, 24] . We analyzed the transcription levels of these CDK inhibitors to evaluate whether changes in their expression could be linked to the observed phenotype in Moz HAT2/2 hematopoietic progenitors. Only transcriptional levels of the tumor suppressor p16
INK4a were significantly altered in Moz HAT2/2 cells (Fig. 1C) . To further investigate whether this upregulation of p16
INK4a was reflecting changes in the transcription levels of known regulators of this tumor suppressor, such as Bmi1 [15, 25] , Ezh1 [26] , Ezh2 [27, 28] , and Suz12 [29] , we analyzed the expression of these genes by qPCR. We found no significant difference in the expression levels of proteins known to control p16
INK4a transcription (Fig. 1C) . We then verified that the transcription levels of p16
INK4a were rapidly upregulated in Moz HAT2/2 hematopoietic progenitors upon culture conditions that promote their proliferation (Fig. 1D) . Higher levels of p16
INK4a protein were also detected in these cells by immunoblotting and immunostaining (Fig. 1E, 1F) Fig. S1B-S1F ). To confirm these ex vivo findings and assess proliferation in vivo, cohorts of reconstituted mice were treated with 5FU to induce HSC entry into cell cycle [31, 32] . (Fig. 2D ), whereas no positive staining was observed in 5FU-treated Wt controls. In addition, 7-10 days after treatment, a high percentage of 5FU-treated mice reconstituted with Moz HAT2/2 had to be euthanized (Fig. 2E ) due to excessive weight loss (Supporting Information Fig. S1G ) associated with the development of low blood counts (Fig. 2F ). These findings are consistent with the profound long-term repopulation potential defect of Moz HAT2/2 HSCs in serial transplantation experiments as documented previously [8] .
Altogether, these experiments demonstrate that the absence of the HAT activity of MOZ either in ESCs derived, fetal or adult hematopoietic progenitors results in cell autonomous proliferative defects triggered by a premature entry into replicative senescence.
NSCs Self-Renewal Relies on MOZ HAT Dependent Silencing of p16
INK4a
MOZ and its close homologue MORF (MOZ related factor, MYST4 or KAT6B) have been assigned specific roles in either hematopoietic or neural development, respectively [33, 34] . However, our previous observation that Moz HAT2/2 ESCs, unlike their Wt counterparts, did not extensively contribute to the formation of the brain in chimeric mice [8] suggests that MOZ, through its HAT activity, might also play a role in regulating the proliferation of NCS/Ps. To test this hypothesis, we first cultured cells isolated from the telencephalon of Wt and Moz HAT2/2 E14.5 embryos under clonogenic conditions to compare their potential to generate self-renewing neurospheres, a measurement of the number of cells with neural stem-like properties [35, 36] . Moz HAT2/2 embryos generated three times less neurospheres than Wt controls (Fig. 3A) suggesting that there are significantly fewer NSCs in the telencephalon of Moz HAT2/2 embryos. In addition, Moz HAT2/2 neurospheres displayed reduced expansion kinetics, producing fewer neurospheres at each passage, with an expansion index fivefold lower than Wt neurospheres (Fig. 3B) , suggesting a reduced self-renewal potential. In fact, no neurospheres could be generated from the MOZ HAT2/2 cells after the third passage. In addition to this (Fig. 3C) , which could be indicative of cell-cycle arrest. BrdU incorporation analysis of Moz HAT2/2 secondary neurospheres revealed a reduced percentage of cells in the S-phase of the cell cycle and accumulation of cells at the G1 phase, similar to the phenotype observed for Moz HAT2/2 hematopoietic progenitors (Fig. 3D) . Consistent with the acquisition of a senescent phenotype, cells from secondary Moz HAT2/2 neurospheres also displayed SA b-gal activity and higher p16
INK4a expression levels than Wt controls (Fig. 3E,  3F ). These in vitro findings were further substantiated in vivo by the observation that a lower percentage of cells expressing aldehyde dehydrogenase (ALDH), a marker of cells with stem-like properties [37, 38] , was detected in brains of E14.5 Moz HAT2/2 (Fig. 4A) . Furthermore, a reduction in the number of cells expressing the proliferation marker Ki67 (Fig. 4B ) and cells incorporating BrdU (Fig. 4C ) was also observed in the brains of E14.5 Moz HAT2/2 embryos. Finally, qPCR analysis of E14.5 telencephalons revealed an increased p16
INK4a expression in the telencephalon of Moz HAT2/2 embryos (Fig. 4D) . Altogether, these data demonstrate that, similarly to the hematopoietic system, Moz HAT2/2 NSC/Ps display proliferative defects ex vivo and in vivo, upregulate the expression of p16
INK4a and readily enter into replicative senescence. INK4a resulted in higher numbers of primary neurospheres generated by telencephalon cells of E14.5 Moz HAT2/2 embryos (Fig. 5D) . Furthermore, serial passage of these primary neurospheres produced numbers of tertiary neurospheres similar of that of the Wt/Wt (Supporting Information  Fig. S2A ), indicating a substantial recovery of the expansion index of Moz HAT2/2 neurospheres in the absence of INK4a (Supporting Information Fig. S2B ). Altogether, these results suggest that the defects observed in these Moz HAT2/2 neural cells are also mediated by the upregulation of p16
. These results indicate that p16
INK4a upregulation in Moz HAT2/2 cells inhibit NSC self-renewal driving cells into replicative senescence in a similar fashion to HSC/Ps lacking MOZ HAT activity. 
